Project Category: Fractions

HB1Y1G

Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and Cryptococcus neoformans and moderate activity against Neisseria gonorrhoeae.
Read more
Project Category: Fractions

HB1Y1E

Sample possesses significant inhibitory activity against Streptococcus pneumoniae and Cryptococcus neoformans and moderate activity against Neisseria gonorrhoeae.
Read more
Project Category: Fractions

HB4Y1B

Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and Cryptococcus neoformans, and moderate activity against Neisseria gonorrhoeae.
Read more
Project Category: Fractions

HB3Y1H

Sample presents significant inhibitory activity against Streptococcus pneumoniae and moderate activity against Streptococcus agalactiae and Cryptococcus neoformans.
Read more
Project Category: Fractions

HB3Y1G

Sample shows significant inhibitory activity against Streptococcus pneumoniae and moderate activity against Neisseria gonorrhoeae.
Read more
Project Category: Fractions

HB4Y1A

Sample exhibits outstanding inhibitory activity against Streptococcus pneumoniae and Streptococcus agalactiae.
Read more
Project Category: Fractions

HB4Y1H

Sample possesses significant inhibitory activity against Streptococcus pneumoniae and moderate activity against Streptococcus agalactiae.
Read more
Project Category: Fractions

HB1Y1H

Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and moderate activity against Streptococcus agalactiae and Cryptococcus neoformans.
Read more
Project Category: Fractions

HB3Y1A

Sample shows remarkable inhibitory activity against Streptococcus pneumoniae, Streptococcus agalactiae, and Cryptococcus neoformans.
Read more
Project Category: Fractions

HB4Y1E

Sample possesses significant inhibitory activity against Streptococcus pneumoniae and moderate activity against Neisseria gonorrhoeae, Streptococcus agalactiae, and Cryptococcus neoformans.
Read more
Project Category: Fractions

HB4Y1F

Sample exhibits significant inhibitory activity against Streptococcus pneumoniae and Streptococcus agalactiae.
Read more
Project Category: Pathogens

MycoCrypto

Cryptococcus neoformans

Cryptococcosis caused by C. neoformans is a very serious disease, with a mortality rate ranging from 41% to 61%, particularly in patients with HIV infection.
Read more